Atrial Fibrillation

Featured Article

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.

Latest News

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.

CHA2DS2-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

CHA2DS2-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.

Atrial Fibrillation Development Predicted by Sleep Disruption

Atrial Fibrillation Development Predicted by Sleep Disruption

Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

Individuals with clinician-diagnosed asthma were at an estimated 38% higher risk for atrial fibrillation.

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.

Latest Features

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Anticoagulation under- and overdoing can be problematic in patients with atrial fibrillation.

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

New ACC/AHA performance and quality measures for atrial fibrillation/flutter include metrics for outpatient care.

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Experts weigh in on cryoablation vs radiofrequency ablation techniques for atrial fibrillation in light of FIRE and ICE trial results.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Sign Up for Free e-Newsletters